Business
Braskem Misses Estimates as Weaker Spreads Offset Sales
By Marcus Chen
Swiss Biotech Windward Raises $225 Million in US IPO, Placement
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Thursday, November 12, 2026 at 11:32 PM · 1 min read
Windward Bio Group AG, raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.
Up nextBraskem Misses Estimates as Weaker Spreads Offset SalesBusiness · 1 min read
